MG 3 receives four stars but suffers rare and serious seat failure in Euro NCAP crash test
LEUVEN, BELGIUM – For decades, MG’s catchy slogan was ‘Safety Fast’ as…
Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025
September 09, 2025 11:00 ET | Source: Chiesi Global Rare Diseases Results…
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by…
Limited Drop, Maximum Flex: Cleveland Golf and SWAG Partner for RTZ Wedge Collaboration
HUNTINGTON BEACH, Calif., Aug. 28, 2025 – When pure contact meets unfiltered…
London musician with brain tumour inspires Brighton triathlon fundraiser
Tuesday 26 August, 2025 A talented musician from London, who died from…
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
RIYADH, Saudi Arabia, Aug. 24, 2025 (GLOBE NEWSWIRE) -- In a rare…
UltraLuxe Singapore 2025 Showcases The Collectable And Investible In Niche Luxury Through Immersive And Social Experiences
SINGAPORE, Aug. 20, 2025 /PRNewswire/ -- From jewellery and fashion to art, wellness,…
Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell
Celebrates Indian Independence Day by Honoring the US-India Innovation PartnershipCAMBRIDGE, Mass.--(BUSINESS WIRE)--$HIND--Vyome…
FDA Approves Apellis EMPAVELI (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
Proven efficacy across all three key markers of disease—68% reduction in proteinuria,…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 18, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…